119-s2121

S
✓ Complete Data

SUPPORT for Patients and Communities Reauthorization Act of 2025

Login to track bills
Introduced:
Jun 18, 2025
Policy Area:
Health

Bill Statistics

2
Actions
8
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Jun 18, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Actions (2)

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Type: IntroReferral | Source: Senate
Jun 18, 2025
Introduced in Senate
Type: IntroReferral | Source: Library of Congress | Code: 10000
Jun 18, 2025

Subjects (1)

Health (Policy Area)

Cosponsors (8)

Text Versions (1)

Introduced in Senate

Jun 18, 2025

Full Bill Text

Length: 57,319 characters Version: Introduced in Senate Version Date: Jun 18, 2025 Last Updated: Nov 12, 2025 6:17 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 2121 Introduced in Senate

(IS) ]

<DOC>

119th CONGRESS
1st Session
S. 2121

To reauthorize certain programs that provide for opioid use disorder
prevention, treatment, and recovery, and for other purposes.

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

June 18, 2025

Mr. Cassidy (for himself, Mr. Sanders, Ms. Murkowski, Ms. Baldwin, Mr.
Mullin, Ms. Hassan, Mr. Tuberville, and Mr. Hickenlooper) introduced
the following bill; which was read twice and referred to the Committee
on Health, Education, Labor, and Pensions

_______________________________________________________________________

A BILL

To reauthorize certain programs that provide for opioid use disorder
prevention, treatment, and recovery, and for other purposes.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.

(a) Short Title.--This Act may be cited as the ``SUPPORT for
Patients and Communities Reauthorization Act of 2025''.

(b) Table of Contents.--The table of contents for this Act is as
follows:
Sec. 1.
TITLE I--PREVENTION
Sec. 101.
Sec. 102.
illicit drug use and other risk factors.
Sec. 103.
Sec. 104.
alcohol spectrum disorder.
Sec. 105.
Sec. 106.
Sec. 107.
Sec. 108.
incidents.
Sec. 109.
Sec. 110.
Sec. 111.
Sec. 112.
Sec. 113.
disorders.
TITLE II--TREATMENT
Sec. 201.
women.
Sec. 202.
Sec. 203.
Sec. 204.
workforce.
Sec. 205.
substance use disorder patient records.
Sec. 206.
identification, referral, and support.
Sec. 207.
Sec. 208.
illness and children with serious emotional
disturbance.
Sec. 209.
combination of buprenorphine and naloxone.
TITLE III--RECOVERY
Sec. 301.
Sec. 302.
Sec. 303.
Sec. 304.
Sec. 305.
Sec. 306.
crisis.
TITLE IV--MISCELLANEOUS MATTERS
Sec. 401.
prescribing practitioner.
Sec. 402.

TITLE I--PREVENTION
SEC. 101.
Section 317L (d) of the Public Health Service Act (42 U.
(d) of the Public Health Service Act (42 U.S.C. 247b-
13
(d) ) is amended by striking ``such sums as may be necessary for each
of the fiscal years 2019 through 2023'' and inserting ``$4,250,000 for
each of fiscal years 2026 through 2030''.
SEC. 102.
ILLICIT DRUG USE AND OTHER RISK FACTORS.
Section 317N (d) of the Public Health Service Act (42 U.
(d) of the Public Health Service Act (42 U.S.C. 247b-
15
(d) ) is amended by striking ``fiscal years 2019 through 2023'' and
inserting ``fiscal years 2026 through 2030''.
SEC. 103.

(a) In General.--
Section 392A of the Public Health Service Act (42 U.
U.S.C. 280b-1) is amended--

(1) in subsection

(a)

(2) --
(A) in subparagraph
(C) , by inserting ``and
associated risks'' before the period at the end; and
(B) in subparagraph
(D) , by striking ``opioids''
and inserting ``substances causing overdose''; and

(2) in subsection

(b)

(2) --
(A) in subparagraph
(B) , by inserting ``, and
associated risk factors,'' after ``such overdoses'';
(B) in subparagraph
(C) , by striking ``coding'' and
inserting ``monitoring and identifying'';
(C) in subparagraph
(E) --
(i) by inserting a comma after ``public
health laboratories''; and
(ii) by inserting ``and other emerging
substances related'' after ``analogues''; and
(D) in subparagraph
(F) , by inserting ``and
associated risk factors'' after ``overdoses''.

(b) Additional Grants.--
Section 392A (a) (3) of the Public Health Service Act (42 U.

(a)

(3) of the Public Health
Service Act (42 U.S.C. 280b-1

(a)

(3) ) is amended--

(1) in the matter preceding subparagraph
(A) , by striking
``and Indian Tribes--'' and inserting ``and Indian Tribes for
the following purposes:'';

(2) by amending subparagraph
(A) to read as follows:
``
(A) To carry out innovative projects for grantees
to detect, identify, and rapidly respond to controlled
substance misuse, abuse, and overdoses, and associated
risk factors, including changes in patterns of such
controlled substance use. Such projects may include the
use of innovative, evidence-based strategies for
detecting such patterns, such as wastewater
surveillance, if proven to support actionable
prevention strategies, in a manner consistent with
applicable Federal and State privacy laws.''; and

(3) in subparagraph
(B) , by striking ``for any'' and
inserting ``For any''.
(c) Authorization of Appropriations.--
Section 392A (e) of the Public Health Service Act (42 U.

(e) of the Public
Health Service Act (42 U.S.C. 280b-1

(e) ) is amended by striking
``$496,000,000 for each of fiscal years 2019 through 2023'' and
inserting ``$505,579,000 for each of fiscal years 2026 through 2030''.
SEC. 104.
ALCOHOL SPECTRUM DISORDER.

(a) In General.--Part O of title III of the Public Health Service
Act (42 U.S.C. 280f et seq.) is amended to read as follows:

``PART O--FETAL ALCOHOL SPECTRUM DISORDER PREVENTION AND SERVICES
PROGRAM

``
SEC. 399H.
AND SERVICES DELIVERY PROGRAM.

``

(a) In General.--The Secretary shall establish or continue
activities to support a comprehensive fetal alcohol spectrum disorders
(referred to in this section as `FASD') education, prevention,
identification, intervention, and services delivery program, which may
include--
``

(1) an education and public awareness program to support,
conduct, and evaluate the effectiveness of--
``
(A) educational programs targeting health
professions schools, social and other supportive
services, educators and counselors and other service
providers in all phases of childhood development, and
other relevant service providers, concerning the
prevention, identification, and provision of services
for infants, children, adolescents, and adults with
FASD;
``
(B) strategies to educate school-age children,
including pregnant and high-risk youth, concerning
FASD;
``
(C) public and community awareness programs
concerning FASD; and
``
(D) strategies to coordinate information and
services across affected community agencies, including
agencies providing social services such as foster care,
adoption, and social work, agencies providing health
services, and agencies involved in education,
vocational training, and civil and criminal justice;
``

(2) supporting and conducting research on FASD, as
appropriate, including to--
``
(A) develop appropriate medical diagnostic
methods for identifying FASD; and
``
(B) develop effective culturally and
linguistically appropriate evidence-based or evidence-
informed interventions and appropriate supports for
preventing prenatal alcohol exposure, which may co-
occur with exposure to other substances;
``

(3) building State and Tribal capacity for the
identification, treatment, and support of individuals with FASD
and their families, which may include--
``
(A) utilizing and adapting existing Federal,
State, or Tribal programs to include FASD
identification and FASD-informed support;
``
(B) developing and expanding screening and
diagnostic capacity for FASD;
``
(C) developing, implementing, and evaluating
targeted FASD-informed intervention programs for FASD;
``
(D) providing training with respect to FASD for
professionals across relevant sectors; and
``
(E) disseminating information about FASD and
support services to affected individuals and their
families; and
``

(4) an applied research program concerning intervention
and prevention to support and conduct service demonstration
projects, clinical studies and other research models providing
advocacy, educational and vocational training, counseling,
medical and mental health, and other supportive services, as
well as models that integrate and coordinate such services,
that are aimed at the unique challenges facing individuals with
FASD and their families.
``

(b) Grants and Technical Assistance.--
``

(1) In general.--The Secretary may award grants,
cooperative agreements, and contracts and provide technical
assistance to eligible entities to carry out subsection

(a) .
``

(2) Eligible entities.--To be eligible to receive a
grant, or enter into a cooperative agreement or contract, under
this section, an entity shall--
``
(A) be a State, Indian Tribe or Tribal
organization, local government, scientific or academic
institution, or nonprofit organization; and
``
(B) prepare and submit to the Secretary an
application at such time, in such manner, and
containing such information as the Secretary may
require, including a description of the activities that
the entity intends to carry out using amounts received
under this section.
``

(3) Additional application contents.--The Secretary may
require that an eligible entity include in the application
submitted under paragraph

(2)
(B) --
``
(A) a designation of an individual to serve as a
FASD State or Tribal coordinator of activities such
eligible entity proposes to carry out through a grant,
cooperative agreement, or contract under this section;
and
``
(B) a description of an advisory committee the
entity will establish to provide guidance for the
entity on developing and implementing a statewide or
Tribal strategic plan to prevent FASD and provide for
the identification, treatment, and support of
individuals with FASD and their families.
``
(c) Definition of FASD Informed.--For purposes of this section,
the term `FASD-informed', with respect to support or an intervention
program, means that such support or intervention program uses
culturally and linguistically informed evidence-based or practice-based
interventions and appropriate resources to support an improved quality
of life for an individual with FASD and the family of such individual.

``
SEC. 399I.
SPECTRUM DISORDERS.

``

(a) In General.--The Secretary shall award grants, contracts, or
cooperative agreements, as the Secretary determines appropriate, to
public or nonprofit private entities with demonstrated expertise in the
field of fetal alcohol spectrum disorders (referred to in this section
as `FASD'). Such awards shall be for the purposes of building local,
Tribal, State, and nationwide capacities to prevent the occurrence of
FASD by carrying out the programs described in subsection

(b) .
``

(b) Programs.--An entity receiving an award under subsection

(a) may use such award for the following purposes:
``

(1) Developing and supporting public education and
outreach activities to raise public awareness of the risks
associated with alcohol consumption during pregnancy.
``

(2) Acting as a clearinghouse for evidence-based
resources on FASD prevention, identification, and culturally
and linguistically appropriate best practices to help inform
systems of care for individuals with FASD across their
lifespan.
``

(3) Increasing awareness and understanding of
efficacious, evidence-based screening tools and culturally and
linguistically appropriate evidence-based intervention services
and best practices, which may include improving the capacity
for State, Tribal, and local affiliates.
``

(4) Providing technical assistance to recipients of
grants, cooperative agreements, or contracts under
section 399H, as appropriate.
``
(c) Application.--To be eligible for a grant, contract, or
cooperative agreement under this section, an entity shall submit to the
Secretary an application at such time, in such manner, and containing
such information as the Secretary may require.
``
(d) Subcontracting.--A public or private nonprofit entity may
carry out the following activities required under this section through
contracts or cooperative agreements with other public and private
nonprofit entities with demonstrated expertise in FASD:
``

(1) Resource development and dissemination.
``

(2) Intervention services.
``

(3) Training and technical assistance.

``
SEC. 399J.

``There are authorized to be appropriated to carry out this part
$12,500,000 for each of fiscal years 2026 through 2030.''.

(b) Report.--Not later than 4 years after the date of enactment of
this Act, and every year thereafter, the Secretary of Health and Human
Services shall prepare and submit to the Committee on Health,
Education, Labor, and Pensions of the Senate and the Committee on
Energy and Commerce of the House of Representatives a report
containing--

(1) a review of the activities carried out pursuant to
sections 399H and 399I of the Public Health Service Act, as
amended by subsection

(a) , to advance public education and
awareness of fetal alcohol spectrum disorders (referred to in
this section as ``FASD'');

(2) a description of--
(A) the activities carried out pursuant to such
sections 399H and 399I to identify, prevent, and treat
FASD; and
(B) methods used to evaluate the outcomes of such
activities; and

(3) an assessment of activities carried out pursuant to
such sections 399H and 399I to support individuals with FASD.
SEC. 105.
Section 399O (h) of the Public Health Service Act (42 U.

(h) of the Public Health Service Act (42 U.S.C. 280g-
3

(h) ) is amended by adding at the end the following:
``

(5) Promoting state choice.--Nothing in this section
shall be construed to authorize the Secretary to require States
to use a specific vendor or a specific interoperability
connection other than to align with nationally recognized,
consensus-based open standards, such as in accordance with
sections 3001 and 3004.''.
SEC. 106.
Section 546 of the Public Health Service Act (42 U.
amended--

(1) in subsection

(a) , by striking ``tribes and tribal''
and inserting ``Tribes and Tribal'';

(2) in subsections

(a) ,
(c) , and
(d) --
(A) by striking ``approved or cleared'' each place
it appears and inserting ``approved, cleared, or
otherwise legally marketed''; and
(B) by striking ``opioid'' each place it appears;

(3) in subsection

(f) --
(A) by striking ``approved or cleared'' each place
it appears and inserting ``approved, cleared, or
otherwise legally marketed'';
(B) in paragraph

(1) , by striking ``opioid'';
(C) in paragraph

(2) --
(i) by striking ``opioid and heroin'' and
inserting ``opioid, heroin, and other drug'';
and
(ii) by striking ``opioid overdose'' and
inserting ``overdose''; and
(D) in paragraph

(3) , by striking ``opioid and
heroin''; and

(4) in subsection

(h) , by striking ``$36,000,000 for each
of fiscal years 2019 through 2023'' and inserting ``$57,000,000
for each of fiscal years 2026 through 2030''.
SEC. 107.

(a) Technical Amendment.--The second part G of title V of the
Public Health Service Act (42 U.S.C. 290kk et seq.), as added by
section 144 of the Community Renewal Tax Relief Act of 2000 (Public Law 106-554), is amended-- (1) by redesignating such part as part J; and (2) by redesignating sections 581 through 584 as sections 596 through 596C, respectively.
106-554), is amended--

(1) by redesignating such part as part J; and

(2) by redesignating sections 581 through 584 as sections
596 through 596C, respectively.

(b) In General.--
Section 582 of the Public Health Service Act (42 U.
U.S.C. 290hh-1) is amended--

(1) in the section heading, by striking ``violence related
stress'' and inserting ``traumatic events'';

(2) in subsection

(a) --
(A) in the matter preceding paragraph

(1) , by
striking ``tribes and tribal'' and inserting ``Tribes
and Tribal''; and
(B) in paragraph

(2) , by inserting ``and
dissemination'' after ``the development'';

(3) in subsection

(b) , by inserting ``and dissemination''
after ``the development'';

(4) in subsection
(d) --
(A) by striking ``The NCTSI'' and inserting the
following:
``

(1) Coordinating center.--The NCTSI''; and
(B) by adding at the end the following:
``

(2) NCTSI grantees.--In carrying out subsection

(a)

(2) ,
NCTSI grantees shall develop trainings and other resources, as
applicable and appropriate, to support implementation of the
evidence-based practices developed and disseminated under such
subsection.'';

(5) in subsection

(e) --
(A) by redesignating paragraphs

(1) and

(2) as
subparagraphs
(A) and
(B) , respectively, and adjusting
the margins accordingly;
(B) in subparagraph
(A) , as so redesignated, by
inserting ``and implementation'' after ``the
dissemination'';
(C) by striking ``The NCTSI'' and inserting the
following:
``

(1) Coordinating center.--The NCTSI''; and
(D) by adding at the end the following:
``

(2) NCTSI grantees.--NCTSI grantees shall, as
appropriate, collaborate with other such grantees, the NCTSI
coordinating center, and the Secretary in carrying out
subsections

(a)

(2) and
(d) (2) .'';

(6) by amending subsection

(h) to read as follows:
``

(h) Application and Evaluation.--To be eligible to receive a
grant, contract, or cooperative agreement under subsection

(a) , a
public or nonprofit private entity or an Indian Tribe or Tribal
organization shall submit to the Secretary an application at such time,
in such manner, and containing such information and assurances as the
Secretary may require, including--
``

(1) a plan for the evaluation of the activities funded
under the grant, contract, or agreement, including both process
and outcomes evaluation, and the submission of an evaluation at
the end of the project period; and
``

(2) a description of how such entity, Indian Tribe, or
Tribal organization will support efforts led by the Secretary
or the NCTSI coordinating center, as applicable, to evaluate
activities carried out under this section.''; and

(7) by amending subsection

(j) to read as follows:
``

(j) Authorization of Appropriations.--There is authorized to be
appropriated to carry out this section--
``

(1) $98,887,000 for fiscal year 2026;
``

(2) $98,887,000 for fiscal year 2027;
``

(3) $98,887,000 for fiscal year 2028;
``

(4) $100,000,000 for fiscal year 2029; and
``

(5) $100,000,000 for fiscal year 2030.''.
SEC. 108.
INCIDENTS.

(a) National Suicide Prevention Lifeline Program.--
Section 520E- 3 (b) of the Public Health Service Act (42 U.
3

(b) of the Public Health Service Act (42 U.S.C. 290bb-36c

(b) ) is
amended--

(1) in paragraph

(4) , by striking ``and'' at the end;

(2) in paragraph

(5) , by striking the period at the end and
inserting ``; and''; and

(3) by adding at the end the following:
``

(6) taking such steps as may be necessary to ensure the
suicide prevention hotline is protected from cybersecurity
incidents and eliminates known cybersecurity
vulnerabilities.''.

(b) Reporting.--
Section 520E-3 of the Public Health Service Act (42 U.
U.S.C. 290bb-36c) is amended--

(1) by redesignating subsection

(f) as subsection

(g) ; and

(2) by inserting after subsection

(e) the following:
``

(f) Cybersecurity Reporting.--
``

(1) Notification.--
``
(A) In general.--The program's network
administrator receiving Federal funding pursuant to
subsection

(a) shall report to the Assistant Secretary,
in a manner that protects personal privacy, consistent
with applicable Federal and State privacy laws--
``
(i) any identified cybersecurity
vulnerabilities to the program within a
reasonable amount of time after identification
of such a vulnerability; and
``
(ii) any identified cybersecurity
incidents to the program within a reasonable
amount of time after identification of such
incident.
``
(B) Local and regional crisis centers.--Local and
regional crisis centers participating in the program
shall report to the program's network administrator
identified under subparagraph
(A) , in a manner that
protects personal privacy, consistent with applicable
Federal and State privacy laws--
``
(i) any identified cybersecurity
vulnerabilities to the program within a
reasonable amount of time after identification
of such vulnerability; and
``
(ii) any identified cybersecurity
incidents to the program within a reasonable
amount of time after identification of such
incident.
``

(2) Notification.--If the program's network administrator
receiving funding pursuant to subsection

(a) discovers, or is
informed by a local or regional crisis center pursuant to
paragraph

(1)
(B) of, a cybersecurity vulnerability or incident,
within a reasonable amount of time after such discovery or
receipt of information, such entity shall report the
vulnerability or incident to the Assistant Secretary.
``

(3) Clarification.--
``
(A) Oversight.--
``
(i) Local and regional crisis centers.--
Except as provided in clause
(ii) , local and
regional crisis centers participating in the
program shall oversee all technology each
center employs in the provision of services as
a participant in the program.
``
(ii) Network administrator.--The
program's network administrator receiving
Federal funding pursuant to subsection

(a) shall oversee the technology each crisis center
employs in the provision of services as a
participant in the program if such oversight
responsibilities are established in the
applicable network participation agreement.
``
(B) Supplement, not supplant.--The cybersecurity
incident reporting requirements under this subsection
shall supplement, and not supplant, cybersecurity
incident reporting requirements under other provisions
of applicable Federal law that are in effect on the
date of the enactment of the SUPPORT for Patients and
Communities Reauthorization Act of 2025.''.
(c) Study.--Not later than 180 days after the date of the enactment
of this Act, the Comptroller General of the United States shall--

(1) conduct and complete a study that evaluates
cybersecurity risks and vulnerabilities associated with the 9-
8-8 National Suicide Prevention Lifeline; and

(2) submit a report on the findings of such study to the
Committee on Health, Education, Labor, and Pensions of the
Senate and the Committee on Energy and Commerce of the House of
Representatives.
SEC. 109.
Section 7131 (e) of the SUPPORT for Patients and Communities Act (42 U.

(e) of the SUPPORT for Patients and Communities Act (42
U.S.C. 242t

(e) ) is amended by striking ``$2,000,000 for each of fiscal
years 2019 through 2023'' and inserting ``$9,000,000 for each of fiscal
years 2026 through 2030''.
SEC. 110.

(a) Youth Prevention and Recovery.--
Section 7102 (c) of the SUPPORT for Patients and Communities Act (42 U.
(c) of the SUPPORT
for Patients and Communities Act (42 U.S.C. 290bb-7a
(c) ) is amended--

(1) in paragraph

(3)
(A)
(i) , by inserting ``, which may
include strategies to increase education and awareness of the
potency and dangers of synthetic opioids (including drugs
contaminated with fentanyl) and, as appropriate, other emerging
drug use or misuse issues'' before the semicolon; and

(2) in paragraph

(4)
(A) , by inserting ``and strategies to
increase education and awareness of the potency and dangers of
synthetic opioids (including drugs contaminated with fentanyl)
and, as appropriate, emerging drug use or misuse issues''
before the semicolon.

(b) Interdepartmental Substance Use Disorders Coordinating
Committee.--
Section 7022 of the SUPPORT for Patients and Communities Act (42 U.
Act (42 U.S.C. 290aa note) is amended--

(1) by striking subsection

(g) and inserting the following:
``

(g) Working Groups.--
``

(1) In general.--The Committee may establish working
groups for purposes of carrying out the duties described in
subsection

(e) . Any such working group shall be composed of
members of the Committee (or the designees of such members) and
may hold such meetings as are necessary to carry out the duties
delegated to the working group.
``

(2) Additional federal interagency work group on fentanyl
contamination of illegal drugs.--
``
(A) Establishment.--The Secretary, acting through
the Committee, shall establish a Federal Interagency
Work Group on Fentanyl Contamination of Illegal Drugs
(referred to in this paragraph as the `Work Group')
consisting of representatives from relevant Federal
departments and agencies on the Committee.
``
(B) Consultation.--The Work Group shall consult
with relevant stakeholders and subject matter experts,
including--
``
(i) State, Tribal, and local subject
matter experts in reducing, preventing, and
responding to drug overdose caused by fentanyl
contamination of illicit drugs; and
``
(ii) family members of both adults and
youth who have overdosed by fentanyl
contaminated illicit drugs.
``
(C) Duties.--The Work Group shall--
``
(i) examine Federal efforts to reduce and
prevent drug overdose by fentanyl-contaminated
illicit drugs;
``
(ii) identify strategies to improve
State, Tribal, and local responses to overdose
by fentanyl-contaminated illicit drugs;
``
(iii) coordinate with the Secretary, as
appropriate, in carrying out activities to
raise public awareness of synthetic opioids and
other emerging drug use and misuse issues;
``
(iv) make recommendations to Congress for
improving Federal programs, including with
respect to the coordination of efforts across
such programs; and
``
(v) make recommendations for educating
youth on the potency and dangers of drugs
contaminated by fentanyl.
``
(D) Annual report to secretary.--The Work Group
shall annually prepare and submit to the Secretary, the
Committee on Health, Education, Labor, and Pensions of
the Senate, and the Committee on Energy and Commerce
and the Committee on Education and Workforce of the
House of Representatives, a report on the activities
carried out by the Work Group under subparagraph
(C) ,
including recommendations to reduce and prevent drug
overdose by fentanyl contamination of illegal drugs, in
all populations, and specifically among youth at risk
for substance misuse.''; and

(2) by striking subsection
(i) and inserting the following:
``
(i) Sunset.--The Committee shall terminate on September 30,
2030.''.
SEC. 111.

(a) In General.--Not later than one year after the date of
enactment of this Act, the Secretary of Health and Human Services, in
consultation with the Administrator of the Drug Enforcement
Administration, shall publish guidance to facilitate the use of at-home
safe disposal systems for applicable drugs.

(b) Contents.--The guidance under subsection

(a) shall include--

(1) recommended standards for effective at-home drug
disposal systems to meet applicable requirements enforced by
the Food and Drug Administration;

(2) recommended information to include as instructions for
use to disseminate with at-home drug disposal systems;

(3) best practices and educational tools to support the use
of an at-home drug disposal system, as appropriate; and

(4) recommended use of licensed health providers for the
dissemination of education, instruction, and at-home drug
disposal systems, as appropriate.
SEC. 112.

(a) In General.--Not later than one year after the date of
enactment of this Act, the Secretary of Health and Human Services
(referred to in this section as the ``Secretary'') shall publish on the
website of the Food and Drug Administration (referred to in this
section as the ``FDA'') a report that outlines a plan for assessing
opioid analgesic drugs that are approved under
section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) that addresses the
public health effects of such opioid analgesic drugs as part of the
benefit-risk assessment and the activities of the FDA that relate to
facilitating the development of nonaddictive medical products intended
to treat pain or addiction. Such report shall include--

(1) an update on the actions taken by the FDA to consider
the effectiveness, safety, benefit-risk profile, and use of
approved opioid analgesic drugs;

(2) a timeline for an assessment of the potential need, as
appropriate, for labeling changes, revised or additional
postmarketing requirements, enforcement actions, or withdrawals
for opioid analgesic drugs;

(3) an overview of the steps that the FDA has taken to
support the development and approval of nonaddictive medical
products intended to treat pain or addiction, and actions
planned to further support the development and approval of such
products; and

(4) an overview of the consideration by the FDA of clinical
trial methodologies for analgesic drugs, including the enriched
enrollment randomized withdrawal methodology, and the benefits
and drawbacks associated with different trial methodologies for
such drugs, incorporating any public input received under
subsection

(b) .

(b) Public Input.--In carrying out subsection

(a) , the Secretary
shall provide an opportunity for public input concerning the regulation
by the FDA of opioid analgesic drugs, including scientific evidence
that relates to conditions of use, safety, or benefit-risk assessment
(including consideration of the public health effects) of such opioid
analgesic drugs.
SEC. 113.
DISORDERS.

The activities carried out pursuant to
section 1003 (b) (4) (A) of the 21st Century Cures Act (42 U.

(b)

(4)
(A) of the
21st Century Cures Act (42 U.S.C. 290ee-3a

(b)

(4)
(A) ) may include
facilitating access to products used to prevent overdose deaths by
detecting the presence of one or more substances, such as fentanyl and
xylazine test strips, to the extent the purchase and possession of such
products is consistent with Federal and State law.

TITLE II--TREATMENT
SEC. 201.
WOMEN.
Section 508 of the Public Health Service Act (42 U.
amended--

(1) in subsection
(d) (11)
(C) , by striking ``providing
health services'' and inserting ``providing health care
services'';

(2) in subsection

(g) --
(A) by inserting ``a plan describing'' after ``will
provide''; and
(B) by adding at the end the following: ``Such plan
may include a description of how such applicant will
target outreach to women disproportionately impacted by
maternal substance use disorder.''; and

(3) in subsection

(s) , by striking ``$29,931,000 for each
of fiscal years 2019 through 2023'' and inserting ``$38,931,000
for each of fiscal years 2026 through 2030''.
SEC. 202.
Section 597 of the Public Health Service Act (42 U.
amended--

(1) in subsection

(a)

(1) , by inserting ``diagnosis,'' after
``related to''; and

(2) in subsection

(b) , by inserting ``addiction medicine,''
after ``psychiatry,''.
SEC. 203.
Section 756 (f) of the Public Health Service Act (42 U.

(f) of the Public Health Service Act (42 U.S.C. 294e-
1

(f) ) is amended by striking ``fiscal years 2023 through 2027'' and
inserting ``fiscal years 2026 through 2030''.
SEC. 204.
WORKFORCE.
Section 781 (j) of the Public Health Service Act (42 U.

(j) of the Public Health Service Act (42 U.S.C. 295h

(j) )
is amended by striking ``$25,000,000 for each of fiscal years 2019
through 2023'' and inserting ``$40,000,000 for each of fiscal years
2026 through 2030''.
SEC. 205.
SUBSTANCE USE DISORDER PATIENT RECORDS.
Section 7053 of the SUPPORT for Patients and Communities Act (42 U.
U.S.C. 290dd-2 note) is amended by striking subsection

(e) .
SEC. 206.
IDENTIFICATION, REFERRAL, AND SUPPORT.
Section 7132 of the SUPPORT for Patients and Communities Act (Public Law 115-271; 132 Stat.
(Public Law 115-271; 132 Stat. 4046) is amended--

(1) in subsection

(b)

(1) --
(A) by redesignating subparagraph
(CC) as
subparagraph
(DD) ; and
(B) by inserting after subparagraph

(BB) the
following:
``
(CC) The Administration for Community Living.'';

(2) in subsection
(d) (1) , in the matter preceding
subparagraph
(A) , by inserting ``, developmental disability
service providers'' before ``, individuals who are''; and

(3) in subsection
(i) , by striking ``2023'' and inserting
``2030''.
SEC. 207.
Section 3203 of the SUPPORT for Patients and Communities Act (21 U.
U.S.C. 823 note) is amended--

(1) by striking subsection

(b) ; and

(2) by striking ``

(a) In General.--The Secretary'' and
inserting the following: ``The Secretary''.
SEC. 208.
ILLNESS AND CHILDREN WITH SERIOUS EMOTIONAL DISTURBANCE.

(a) Review of Use of Certain Funding.--Not later than 1 year after
the date of enactment of this Act, the Secretary of Health and Human
Services (referred to in this section as the ``Secretary''), acting
through the Assistant Secretary for Mental Health and Substance Use,
shall conduct a review of State use of funds made available under the
Community Mental Health Services Block Grant program under subpart I of
part B of title XIX of the Public Health Service Act (42 U.S.C. 300x et
seq.) (referred to in this section as the ``block grant program'') for
first episode psychosis activities. Such review shall consider the
following:

(1) How States use funds for evidence-based treatments and
services according to the standard of care for individuals with
early serious mental illness and children with a serious
emotional disturbance.

(2) The percentages of the State funding under the block
grant program expended on early serious mental illness and
first episode psychosis, and the number of individuals served
under such funds.

(b) Report and Guidance.--

(1) Report.--Not later than 180 days after the completion
of the review under subsection

(a) , the Secretary shall submit
to the Committee on Health, Education, Labor, and Pensions and
the Committee on Appropriations of the Senate and the Committee
on Energy and Commerce and the Committee on Appropriations of
the House of Representatives a report describing--
(A) the findings of the review under subsection

(a) ; and
(B) any recommendations for changes to the block
grant program that would facilitate improved outcomes
for individuals with serious mental illness and
children with serious emotional disturbance.

(2) Guidance.--Not later than 1 year after the date on
which the report is submitted under paragraph

(1) , the
Secretary shall update the guidance provided to States under
the block grant program on coordinated specialty care and other
evidence-based mental health care services for individuals with
serious mental illness and children with a serious emotional
disturbance, based on the findings and recommendations of such
report.
SEC. 209.
COMBINATION OF BUPRENORPHINE AND NALOXONE.

(a) Secretary of HHS.--The Secretary of Health and Human Services
shall, consistent with the requirements and procedures set forth in
sections 201 and 202 of the Controlled Substances Act (21 U.S.C. 811,
812)--

(1) review the relevant data pertaining to the scheduling
of products containing a combination of buprenorphine and
naloxone that have been approved under
section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355); and

(2) if appropriate, request that the Attorney General
initiate rulemaking proceedings to revise the schedules
accordingly with respect to such products.

(b) Attorney General.--The Attorney General shall review any
request made by the Secretary of Health and Human Services under
subsection

(a)

(2) and determine whether to initiate proceedings to
revise the schedules in accordance with the criteria set forth in
sections 201 and 202 of the Controlled Substances Act (21 U.S.C. 811,
812).

TITLE III--RECOVERY
SEC. 301.
Section 547 (f) of the Public Health Service Act (42 U.

(f) of the Public Health Service Act (42 U.S.C. 290ee-
2

(f) ) is amended by striking ``$5,000,000 for each of fiscal years 2019
through 2023'' and inserting ``$17,000,000 for each of fiscal years
2026 through 2030''.
SEC. 302.
Section 547A of the Public Health Service Act (42 U.
is amended--

(1) in subsection

(b)

(4) , by striking ``building; and'' and
inserting the following: ``building, such as--
``
(A) professional development of peer support
specialists; and
``
(B) making recovery support services available in
nonclinical settings; and'';

(2) by redesignating subsections
(d) and

(e) as subsections

(e) and

(f) , respectively;

(3) by inserting after subsection
(c) the following:
``
(d) Regional Centers.--
``

(1) In general.--The Secretary may establish one regional
technical assistance center (referred to in this subsection as
the `Regional Center'), with existing resources, to assist the
Center in carrying out activities described in subsection

(b) within the geographic region of such Regional Center in a
manner that is tailored to the needs of such region.
``

(2) Evaluation.--Not later than 4 years after the date of
enactment of the SUPPORT for Patients and Communities
Reauthorization Act of 2025, the Secretary shall evaluate the
activities of the Regional Center and submit to the Committee
on Health, Education, Labor, and Pensions of the Senate and the
Committee on Energy and Commerce of the House of
Representatives a report on the findings of such evaluation,
including--
``
(A) a description of the distinct roles and
responsibilities of the Regional Center and the Center;
``
(B) available information relating to the
outcomes of the Regional Center under this subsection,
such as any impact on the operations and efficiency of
the Center relating to requests for technical
assistance and support within the region of such
Regional Center;
``
(C) a description of any gaps or areas of
duplication relating to the activities of the Regional
Center and the Center within such region; and
``
(D) recommendations relating to the modification,
expansion, or termination of the Regional Center under
this subsection.
``

(3) Termination.--This subsection shall terminate on
September 30, 2030.''; and

(4) in subsection

(f) , as so redesignated, by striking
``$1,000,000 for each of fiscal years 2019 through 2023'' and
inserting ``$2,000,000 for each of fiscal years 2026 through
2030''.
SEC. 303.
Section 552 of the Public Health Service Act (42 U.
amended--

(1) in subsection
(d) (2) --
(A) in the matter preceding subparagraph
(A) , by
striking ``and in such manner'' and inserting ``, in
such manner, and containing such information and
assurances, including relevant documentation,''; and
(B) in subparagraph
(A) , by striking ``is capable
of coordinating with other entities to carry out'' and
inserting ``has the demonstrated capability to carry
out, through referral or contractual arrangements'';

(2) in subsection

(h) --
(A) by redesignating paragraphs

(1) through

(4) as
subparagraphs
(A) through
(D) , respectively, and
adjusting the margins accordingly;
(B) by striking ``With respect to'' and inserting
the following:
``

(1) In general.--With respect to''; and
(C) by adding at the end the following:
``

(2) Additional reporting for certain eligible entities.--
An entity carrying out activities described in subsection

(g) through referral or contractual arrangements shall include in
the submissions required under paragraph

(1) information
related to the status of such referrals or contractual
arrangements, including an assessment of whether such referrals
or contractual arrangements are supporting the ability of such
entity to carry out such activities.''; and

(3) in subsection

(j) , by striking ``2019 through 2023''
and inserting ``2026 through 2030''.
SEC. 304.
Section 7102 (c) of the SUPPORT for Patients and Communities Act (42 U.
(c) of the SUPPORT for Patients and Communities Act (42
U.S.C. 290bb-7a
(c) ) (as amended by
section 110 (a) ) is amended-- (1) in paragraph (2) -- (A) in subparagraph (A) -- (i) in clause (i) -- (I) by inserting ``, or a consortium of local educational agencies,'' after ``a local educational agency''; and (II) by striking ``high schools'' and inserting ``secondary schools''; and (ii) in clause (vi) , by striking ``tribe, or tribal'' and inserting ``Tribe, or Tribal''; (B) by amending subparagraph (E) to read as follows: `` (E) Indian tribe; tribal organization.

(a) ) is amended--

(1) in paragraph

(2) --
(A) in subparagraph
(A) --
(i) in clause
(i) --
(I) by inserting ``, or a
consortium of local educational
agencies,'' after ``a local educational
agency''; and
(II) by striking ``high schools''
and inserting ``secondary schools'';
and
(ii) in clause
(vi) , by striking ``tribe,
or tribal'' and inserting ``Tribe, or Tribal'';
(B) by amending subparagraph
(E) to read as
follows:
``
(E) Indian tribe; tribal organization.--The terms
`Indian Tribe' and `Tribal organization' have the
meanings given such terms in
section 4 of the Indian Self-Determination and Education Assistance Act (25 U.
Self-Determination and Education Assistance Act (25
U.S.C. 5304).'';
(C) by redesignating subparagraph
(K) as
subparagraph
(L) ; and
(D) by inserting after subparagraph
(J) the
following:
``
(K) Secondary school.--The term `secondary
school' has the meaning given such term in
section 8101 of the Elementary and Secondary Education Act of 1965 (20 U.
of the Elementary and Secondary Education Act of 1965
(20 U.S.C. 7801).'';

(2) in paragraph

(3)
(A) , in the matter preceding clause
(i) --
(A) by striking ``and abuse''; and
(B) by inserting ``at increased risk for substance
misuse'' after ``specific populations'';

(3) in paragraph

(4) --
(A) in the matter preceding subparagraph
(A) , by
striking ``Indian tribes'' and inserting ``Indian
Tribes'';
(B) in subparagraph
(A) , by striking ``and abuse'';
and
(C) in subparagraph
(B) , by striking ``peer
mentoring'' and inserting ``peer-to-peer support'';

(4) in paragraph

(5) , by striking ``tribal'' and inserting
``Tribal'';

(5) in paragraph

(6)
(A) --
(A) in clause
(iv) , by striking ``; and'' and
inserting a semicolon; and
(B) by adding at the end the following:
``
(vi) a plan to sustain the activities
carried out under the grant program, after the
grant program has ended; and'';

(6) in paragraph

(8) , by striking ``2022'' and inserting
``2028''; and

(7) by amending paragraph

(9) to read as follows:
``

(9) Authorization of appropriations.--To carry out this
subsection, there are authorized to be appropriated--
``
(A) $10,000,000 for fiscal year 2026;
``
(B) $12,000,000 for fiscal year 2027;
``
(C) $13,000,000 for fiscal year 2028;
``
(D) $14,000,000 for fiscal year 2029; and
``
(E) $15,000,000 for fiscal year 2030.''.
SEC. 305.

(a) In General.--
Section 7183 of the SUPPORT for Patients and Communities Act (42 U.
Communities Act (42 U.S.C. 290ee-8) is amended--

(1) in the section heading, by inserting ``; treatment,
recovery, and workforce support grants'' after ``career act'';

(2) in subsection

(b) , by inserting ``each'' before ``for a
period'';

(3) in subsection
(c) --
(A) in paragraph

(1) , by striking ``the rates
described in paragraph

(2) '' and inserting ``the
average rates for calendar years 2018 through 2022
described in paragraph

(2) ''; and
(B) by amending paragraph

(2) to read as follows:
``

(2) Rates.--The rates described in this paragraph are the
following:
``
(A) The highest age-adjusted average rates of
drug overdose deaths for calendar years 2018 through
2022 based on data from the Centers for Disease Control
and Prevention, including, if necessary, provisional
data for calendar year 2022.
``
(B) The highest average rates of unemployment for
calendar years 2018 through 2022 based on data provided
by the Bureau of Labor Statistics.
``
(C) The lowest average labor force participation
rates for calendar years 2018 through 2022 based on
data provided by the Bureau of Labor Statistics.'';

(4) in subsection

(g) --
(A) in each of paragraphs

(1) and

(3) , by
redesignating subparagraphs
(A) and
(B) as clauses
(i) and
(ii) , respectively, and adjusting the margins
accordingly;
(B) by redesignating paragraphs

(1) through

(3) as
subparagraphs
(A) through
(C) , respectively, and
adjusting the margins accordingly;
(C) in the matter preceding subparagraph
(A) (as so
redesignated), by striking ``An entity'' and inserting
the following:
``

(1) In general.--An entity''; and
(D) by adding at the end the following:
``

(2) Transportation services.--An entity receiving a grant
under this section may use not more than 5 percent of the funds
for providing transportation for individuals to participate in
an activity supported by a grant under this section, which
transportation shall be to or from a place of work or a place
where the individual is receiving vocational education or job
training services or receiving services directly linked to
treatment of or recovery from a substance use disorder.
``

(3) Limitation.--The Secretary may not require an entity
to, or give priority to an entity that plans to, use the funds
of a grant under this section for activities that are not
specified in this subsection.'';

(5) in subsection
(i) (2) , by inserting ``, which shall
include employment and earnings outcomes described in
subclauses
(I) and
(III) of
section 116 (b) (2) (A) (i) of the Workforce Innovation and Opportunity Act (29 U.

(b)

(2)
(A)
(i) of the
Workforce Innovation and Opportunity Act (29 U.S.C.
3141

(b)

(2)
(A)
(i) ) with respect to the participation of such
individuals with a substance use disorder in programs and
activities funded by the grant under this section'' after
``subsection

(g) '';

(6) in subsection

(j) --
(A) in paragraph

(1) , by inserting ``for grants
awarded prior to the date of enactment of the SUPPORT
for Patients and Communities Reauthorization Act of
2025'' after ``grant period under this section''; and
(B) in paragraph

(2) --
(i) in the matter preceding subparagraph
(A) , by striking ``2 years after submitting the
preliminary report required under paragraph

(1) '' and inserting ``September 30, 2030''; and
(ii) in subparagraph
(A) , by striking
``

(g)

(3) '' and inserting ``

(g)

(1)
(C) ''; and

(7) in subsection

(k) , by striking ``$5,000,000 for each of
fiscal years 2019 through 2023'' and inserting ``$12,000,000
for each of fiscal years 2026 through 2030''.

(b) Reauthorization of the CAREER Act; Recovery Housing Pilot
Program.--

(1) In general.--
Section 8071 of the SUPPORT for Patients and Communities Act (42 U.
and Communities Act (42 U.S.C. 5301 note; Public Law 115-271)
is amended--
(A) by striking the section heading and inserting
``career act; recovery housing pilot program'';
(B) in subsection

(a) , by striking ``through 2023''
and inserting ``through 2030'';
(C) in subsection

(b) --
(i) in paragraph

(1) , by striking ``not
later than 60 days after the date of enactment
of this Act'' and inserting ``not later than 60
days after the date of enactment of the SUPPORT
for Patients and Communities Reauthorization
Act of 2025''; and
(ii) in paragraph

(2)
(B)
(i) --
(I) in subclause
(I) --

(aa) by striking ``for
calendar years 2013 through
2017''; and

(bb) by inserting ``for
calendar years 2018 through
2022'' after ``rates of
unemployment'';
(II) in subclause
(II) --

(aa) by striking ``for
calendar years 2013 through
2017''; and

(bb) by inserting ``for
calendar years 2018 through
2022'' after ``participation
rates''; and
(III) by striking subclause
(III) and inserting the following:
``
(III) The highest age-adjusted
average rates of drug overdose deaths
for calendar years 2018 through 2022
based on data from the Centers for
Disease Control and Prevention,
including, if necessary, provisional
data for calendar year 2022.''; and
(D) in subsection

(f) , by striking ``For the 2-year
period following the date of enactment of this Act,
the'' and inserting ``The''.

(2) Conforming amendment.--Subtitle F of title VIII of the
SUPPORT for Patients and Communities Act (Public Law 115-271;
132 Stat. 4095) is amended by striking the subtitle heading and
inserting the following: ``CAREER Act; Recovery Housing Pilot
Program'' .
(c) Clerical Amendments.--The table of contents in
section 1 (b) of the SUPPORT for Patients and Communities Act (Public Law 115-271; 132 Stat.

(b) of
the SUPPORT for Patients and Communities Act (Public Law 115-271; 132
Stat. 3894) is amended--

(1) by striking the item relating to
section 7183 and inserting the following: ``
inserting the following:

``
Sec. 7183.
grants.'';

(2) by striking the item relating to subtitle F of title
VIII and inserting the following:

``Subtitle F--CAREER Act; Recovery Housing Pilot Program''; and

(3) by striking the item relating to
section 8071 and inserting the following: ``
inserting the following:

``
Sec. 8071.
SEC. 306.
CRISIS.
Section 8041 (g) (1) of the SUPPORT for Patients and Communities Act (29 U.

(g)

(1) of the SUPPORT for Patients and Communities Act
(29 U.S.C. 3225a

(g)

(1) ) is amended by striking ``2023'' and inserting
``2030''.

TITLE IV--MISCELLANEOUS MATTERS
SEC. 401.
PRESCRIBING PRACTITIONER.
Section 309A (a) of the Controlled Substances Act (21 U.

(a) of the Controlled Substances Act (21 U.S.C.
829a

(a) ) is amended by striking paragraph

(2) and inserting the
following:
``

(2) the controlled substance is a drug in schedule III,
IV, or V to be administered--
``
(A) by injection or implantation for the purpose
of maintenance or detoxification treatment; or
``
(B) subject to a risk evaluation and mitigation
strategy pursuant to
section 505-1 of the Federal Food, Drug, and Cosmetic Act (21 U.
Drug, and Cosmetic Act (21 U.S.C. 355-1) that includes
elements to assure safe use of the drug described in
subsection

(f)

(3)
(E) of such section, including a
requirement for post-administration monitoring by a
health care provider;''.
SEC. 402.

(a) In General.--
Section 303 of the Controlled Substances Act (21 U.
U.S.C. 823) is amended--

(1) by redesignating the second subsection designated as
subsection
(l) as subsection
(m) ; and

(2) in subsection
(m) (1) , as so redesignated--
(A) in subparagraph
(A) --
(i) in clause
(iv) --
(I) in subclause
(I) --

(aa) by inserting ``the
American Academy of Family
Physicians, the American
Podiatric Medical Association,
the Academy of General
Dentistry, the American
Optometric Association,''
before ``or any other
organization'';

(bb) by striking ``or the
Commission'' and inserting ``,
the Commission''; and
(cc) by inserting ``, or
the Council on Podiatric
Medical Education'' before the
semicolon at the end; and
(II) in subclause
(III) , by
inserting ``or the American Academy of
Family Physicians'' after
``Association''; and
(ii) in clause
(v) , in the matter preceding
subclause
(I) --
(I) by striking ``osteopathic
medicine, dental surgery'' and
inserting ``osteopathic medicine,
podiatric medicine, dental surgery'';
and
(II) by striking ``or dental
medicine curriculum'' and inserting
``or dental or podiatric medicine
curriculum''; and
(B) in subparagraph
(B) --
(i) in clause
(i) --
(I) by inserting ``the American
Pharmacists Association, the
Accreditation Council on Pharmacy
Education, the American Psychiatric
Nurses Association, the American
Academy of Nursing, the American
Academy of Family Physicians,'' before
``or any other organization''; and
(II) by inserting ``, the American
Academy of Family Physicians,'' before
``or the Accreditation Council''; and
(ii) in clause
(ii) --
(I) by striking ``or accredited
school'' and inserting ``, an
accredited school''; and
(II) by inserting ``, or an
accredited school of pharmacy'' before
``in the United States''.

(b) Effective Date.--The amendments made by subsection

(a) shall
take effect as if enacted on December 29, 2022.
<all>